Very low LDL (below 50-70 mg/dL) achieved through aggressive medication raises theoretical concerns about reduced hormone production, potential cognitive effects, and increased hemorrhagic stroke risk in some populations
A sudden, sustained improvement in glucose markers without corresponding changes in diet or exercise habits is one of the clearest laboratory signatures of GLP-1 therapy
While large Ozempic/Wegovy trials dont typically report estrogen/progesterone changes, smaller studies (especially in PCOS) have measured reproductive hormones
Push the plunger slowly to expel air and excess liquid back into the vial until you hit your exact target marking
Corinne, you receive: Thorough evaluation to determine whether oral or injectable GLP-1 medicationor another approachbest fits your health profile and goals Ongoing monitoring of metabolic markers, nutrient levels, and body compositionnot just the number on the scale Evidence-based protocols to preserve muscle mass, support energy levels, and minimize side effects Direct access to your physician, not just a prescription service The FDA approval of oral Wegovy is exciting news for patients seeking effective weight loss treatment